MIL-OSI Russia: A new laboratory will be opened at the Institute of Medicine and Medical Technologies of NSU

Translartion. Region: Russians Fedetion –

Source: Novosibirsk State University – Novosibirsk State University –

Last week, innovative companies Papillon and SafeVision signed a cooperation agreement with Novosibirsk State University. Plans for 2025-2026 include opening a laboratory based Institute of Medicine and Medical Technologies NSU (IMMT NSU) to combine efforts in the development of new treatment methods and the use of an innovative medical bed, as well as a Medical Decision Support System.

This agreement is the first step towards interaction between the organizations, allowing for the creation of a long-term scientific and educational partnership. As a result, it is planned to create a Laboratory integrated into the educational process in the specialty “Medical Cybernetics” – this is a new direction, the first recruitment for which will take place in September 2025.

Students will be involved in the company’s production activities as part of their diploma projects. This will allow for the unification of efforts in developing new treatment methods using the potential of medical equipment and new approaches to AI, computer vision and machine learning for monitoring patients. The main goal is to create a scientific base where students and teachers will conduct their scientific research, publishing the results in international journals.

Mikhail Khvostov, Acting Dean Faculty of Pharmacy and Medical Cybernetics, IMMT NSU, Doctor of Biological Sciences, commented:

— One of the tasks of medical cybernetics is to create smart devices for interaction with patients. It is very important that during the training process, students could see live how such devices are created, and most importantly — take part in their creation. In cooperation with dynamically developing companies, I see huge potential in both the educational and scientific spheres for students of the new training program — the specialty “Medical Cybernetics”, opened at the Faculty of Pharmacy and Medical Cybernetics of the IMMT NSU.

Igor Mendzebrovsky, Development Director of Papillon LLC and SafeVision LLC, noted:

— We provide our products as a platform for students. They can form new solutions and even new business concepts. We help them make their idea as viable as possible, for example, if students want to turn their solution into a product, get a registration certificate and bring it to market.

Several working groups of 2nd and 3rd year students of the NSU Institute of Intelligent Robotics have already been created. Computer science students are working on creating algorithms for the SafeVision software and hardware complex, designed for contactless monitoring of the patient’s condition and risk factor analysis. For example, active work is underway to identify APNEA syndrome in patients (sleep apnea for more than 10 seconds): the device will be able to identify such a disorder in a patient and signal the doctor about it.

Anton Meleshkin, scientific programs manager at SafeVision LLC, senior researcher at the SB RAS IT, PhD in engineering, senior lecturer at NSU, added:

— We develop technological startups, which means we work at the cutting edge of science and technology. We see NSU as a great partner with whom we can build long-term cooperation not only in joint research, but also in the educational process. Our developments can be useful for students to conduct laboratory work, and as topics for course and diploma theses.

For reference:

Papillon LLC — a domestic developer and manufacturer of functional medical beds equipped with automated functions to increase comfort, reduce patient trauma and minimize the burden on medical personnel.

SafeVision LLC — a domestic developer and manufacturer of AI-based medical decision support systems (MDSS) for contactless monitoring of the condition of patients in a medical facility.

Please note: This information is raw content directly from the source of the information. It is exactly what the source states and does not reflect the position of MIL-OSI or its clients.

MIL OSI Russia News